Measles, mumps, and rubella virus vaccine, live (GlaxoSmithKline)

N/A

Report date: 2022/06/13 13:36:18

Base Information

Drug NameMeasles, mumps, and rubella virus vaccine, live (GlaxoSmithKline)
Drug Alias NameMMR vaccine-GlaxoSmithKlineMMR vaccine-Bio-ManguinhosMMR vaccine (GlaxoSmithKline)MMR vaccine - Bio-ManguinhosPriorix +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaMumpsMeasles
Global Approved IndicationsRubellaMumpsMeasles
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date1997/11/25
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcImmunobiological Technology Institute
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Gmbh & Co. KgGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsRubellaMumpsMeasles
Inactive IndicationsN/A

Other Information

ATC CodeJ07BX
Related LinksN/A